Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma

NCT06014905 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Meningioma

Interventions

DRUG: Hyperpolarized carbon C 13 pyruvate
PROCEDURE: Magnetic Resonance Image (MRI)
OTHER: Saline

Sponsor

Javier Villaneuva-Meyer, MD

Collaborators

[object Object]
[object Object]
[object Object]